Hirasawa Y, Adachi T, Hashimoto T, Fukuokaya W, et al. Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan. J Cancer Res Clin Oncol 2024;150:182.
PMID: 38592548